MACQUARIE GROUP LTD - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 175 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$54,000
-25.0%
1,731
-38.6%
0.00%
Q2 2022$72,0000.0%2,8180.0%0.00%
Q1 2022$72,000
-39.0%
2,8180.0%0.00%
Q4 2021$118,000
+353.8%
2,818
+363.5%
0.00%
Q3 2021$26,0006080.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
SB INVESTMENT ADVISERS (UK) LTD 22,616,666$284,405,0003.12%
INDUS CAPITAL PARTNERS, LLC 681,936$8,575,0001.68%
Alphabet Inc. 1,666,666$20,958,0001.27%
Temasek Holdings (Private) Ltd 5,499,999$69,162,0000.45%
Board of Trustees of The Leland Stanford Junior University 38,905$490,0000.06%
Baillie Gifford 500,000$6,287,0000.01%
Marshall Wace North America L.P. 74,898$941,0000.01%
Capital International Investors 983,300$12,365,0000.00%
Blackstone Inc. 35,000$440,0000.00%
Tower Research Capital LLC (TRC) 1,908$24,0000.00%
View complete list of VIR BIOTECHNOLOGY INC shareholders